Watch List: American Diversified Holdings (OTCMKTS:ADHC), Oncomed Pharmaceuticals (NASDAQ:OMED), Concert Pharmaceuticals (NASDAQ:CNCE), Actinium Pharmaceuticals (NYSEMKT:ATNM)

Technology Stocks News 20

American Diversified Holdings Corp (OTCMKTS:ADHC) stock performance was -16.67% in last session and finished the day at $0.0375. Traded volume was 506,482.00million shares in the last session. The beta of the stock remained 3.20.

OncoMed Pharmaceuticals Inc said it halted patient enrollment and dosing in all ongoing early-stage trials of two of its experimental cancer drugs over concerns of bone damage. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) dropped -5.76 percent to $23.09Monday on volume of 190,309.00million shares. The intra-day range of the stock was $23.02 to $24.49. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) has a market capitalization of $682.27million.

Equities researchers at Roth Capital started coverage on shares of Concert Pharmaceuticals (NASDAQ:CNCE) in a research report issued on Thursday. The firm set a “buy” rating and a $28.00 price target on the stock. Roth Capital’s price target indicates a potential upside of 216.74% from the company’s current price. Concert Pharmaceuticals Inc (NASDAQ:CNCE)’s stock on June 23, 2014 reported a decrease of -8.60% to the closing price of $9.56. Its fifty two weeks range is $7.12-$16.26. The total market capitalization recorded $171.12million. The overall volume in the last trading session was 186,733.00million shares. In its share capital, CNCE has 17.90million outstanding shares.

Actinium Pharmaceuticals Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”) a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers is set to join the broad-market Russell 3000® Index as well as the Russell 2000®Russell Global and Russell Microcap® indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27 according to a preliminary list of additions posted June 13 on www.russell.com/indexes. Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) stock performance was -10.07% in last session and finished the day at $8.84. Traded volume was 169,394.00million shares in the last session and the average volume of the stock remained 66.74K shares. The beta of the stock remained 17.80.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone